Uveitis is an infection of the eye's middle layer, which contains many of the eye's blood vessels, whereas Scleritis is an inflammation of the white component of the eye. Scleral inflammation that extends to the anterior uveal tract is a sign of a more serious condition with ocular consequences that can lead to progressive vision loss. When anterior uveitis develops throughout the course of scleritis, the ocular prognosis is poor. The severity of scleritis-related uveitis ranged from mild to moderate, and it was always linked to active scleritis.
• Diagnosis and Management
• Risk Factors
• Medical Conditions
The Uveitis Treatment Market Size is expected to grow from 414.9 million USD In 2020 to reach 544.7 Million USD by 2026 at 4.6% CAGR.
ALSO READ Biochemistry and Molecular Biology Cataract Clinical and Epidemiologic Research Clinical ophthalmology Cornea Diabetic Retinopathy External Eye Disease Eye Anatomy Eye Infections and Allergies Glaucoma Immunology and Microbiology Lens Disorder Nano Ophthalmology Neuro Ophthalmology Ocular Inflammation Ocular Oncology Ophthalmic Pathology Ophthalmology Surgery Optometry Paediatric Ophthalmology Pharmacology Regenerative Medicine Retina Retinal Cell Biology Retinal Imaging Spatial Vision Translational Research Uveitis Scleritis Vision Therapy Vitreous Disorders
Cornea Conferences Ophthalmologists Conferences Ophthalmology Conferences 2022 Pediatric Ophthalmology Conferences Eye Conferences Ophthalmology Conferences 2022 Europe Cataract Conferences Vision Science Conferences